Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 640

Results For "PAT"

6757 News Found

DGCI gives a go-ahead for Phase III Sputnik Light trials
News | September 16, 2021

DGCI gives a go-ahead for Phase III Sputnik Light trials

The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines


Allianz Partners expands its Digital Health Assistant to India
Digitisation | September 16, 2021

Allianz Partners expands its Digital Health Assistant to India

Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals and is part of its Digital Access to Care Initiative


Lupin to settle litigations over diabetes drug
News | September 16, 2021

Lupin to settle litigations over diabetes drug

The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval


Roche set to acquire long-term partner TIB Molbiol
Biotech | September 16, 2021

Roche set to acquire long-term partner TIB Molbiol

The deal is expected to close in the fourth quarter of 2021 and will enable Roche to further expand the portfolio. TIB Molbiol excels in ultra-rapid assay development of emerging infectious diseases


NCLT approves amalgamation of Lincoln Parenteral with Lincoln Pharma
News | September 16, 2021

NCLT approves amalgamation of Lincoln Parenteral with Lincoln Pharma

The amalgamation is expected to bring in a lot of synergies in terms of operational efficiency and productivity for the combined entity


Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment
News | September 15, 2021

Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment

These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients


Jharkhand to set up pharma park
Policy | September 15, 2021

Jharkhand to set up pharma park

The pharma park will be built at an estimated cost of Rs 34.94 crore and will be spread over 50 acres at Chanho close to Ranchi


Apollo Cancer Centres launch India’s first virtual duathlon
Hospitals | September 15, 2021

Apollo Cancer Centres launch India’s first virtual duathlon

Proceeds raised from the duathlon will go towards cancer treatment of children identified by the hospital


Lupin launch a generic version of pain reliever for osteoarthritis in the US
Drug Approval | September 15, 2021

Lupin launch a generic version of pain reliever for osteoarthritis in the US

Ibuprofen and Famotidine tablets (Duexise) had estimated annual sales of US $ 765 million in the US as if July 21


World’s first clinical trial for a rare headache disorder
Biotech | September 15, 2021

World’s first clinical trial for a rare headache disorder

The trial will evaluate the efficacy of psilocybin in Short-lasting Unilateral Neuralgiform Headache Attacks (SUNHA). The data is expected in early 2022